Worth Venture Partners, LLC Delcath Systems, Inc. Transaction History

Worth Venture Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$2.25 - $4.17 $662,058 - $1.23 Million	294,248 New	294,248 $1.22 Million
Q4 2020 Feb 17, 2021	SELL	$10.55 - $18.69 $238,408 - $422,356	-22,598 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$8.8 - $12.84 $25,537 - $37,261	-2,902 Reduced 11.38%	22,598 $263,000
Q2 2020 Aug 14, 2020	BUY	$7.31 - $13.0 $186,405 - $331,500	25,500 New	25,500 $262,000

7.52M

198K

41.7K

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $132M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.